MDA Telethon 2011

MDA is the nation’s largest nongovernmental funder of scientific research seeking cures and treatments for the more than 40 neuromuscular diseases in its program.
MDA funds more than 300 research projects worldwide.
In 2011, MDA will spend almost $39 million on research.
MDA has the most comprehensive services program of any voluntary health agency in the U.S.
MDA supports approximately 200 clinics and some 40 specialized MDA/ALS centers.
MDA holds 80 summer camp sessions for some 3,500 kids with muscle disease.
MDA is the first nonprofit organization recognized with a Lifetime Achievement Award from the American Medical Association.
What is muscular dystrophy? Muscular dystrophy refers to a group of genetic muscle diseases.
MDA’s Augie’s Quest initiative funds ALS TDI, the single-largest ALS drug discovery project in history.
MDA researchers identified the cause of a rare form of spinal muscular atrophy (SMA).
MDA clinics are staffed by top health professionals skilled in the diagnosis and medical management of muscle disease.
MDA partners with biopharmaceutical companies on translational research projects that turn basic science into practical and effective treatments.
MDA-funded research has led to the FDA-approved drug Myozyme, which today is saving the lives of children with Pompe disease (acid maltase deficiency).
The diseases under MDA's umbrella include disorders of muscle, nerve and the neuromuscular junction.
MDA funds innovative strategies being tested in human clinical trials.
MDA has funded the discovery of the genetic underpinnings of almost all diseases (we have more than 40) in its program.
MDA research holds the promises of minimizing symptoms, prolonging life and potentially reversing the course of diseases.